0001022079-18-000151.txt : 20180705
0001022079-18-000151.hdr.sgml : 20180705
20180705163807
ACCESSION NUMBER: 0001022079-18-000151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180705
DATE AS OF CHANGE: 20180705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cunningham Everett
CENTRAL INDEX KEY: 0001564777
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 18940998
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_153082307077479.xml
FORM 4
X0306
4
2018-07-02
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001564777
Cunningham Everett
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
SVP, Commercial
Common Stock
2018-07-02
4
M
0
21294
52.165
A
67210
D
Common Stock
2018-07-02
4
S
0
19798
109.642
D
47412
D
Common Stock
2018-07-02
4
S
0
1496
110.122
D
45916
D
Common Stock
2018-07-02
4
M
0
38928
66.51
A
84844
D
Common Stock
2018-07-02
4
S
0
33345
109.596
D
51499
D
Common Stock
2018-07-02
4
S
0
5583
110.066
D
45916
D
Common Stock
2018-07-02
4
S
0
7066
109.627
D
38850
D
Common Stock
2018-07-02
4
S
0
781
110.124
D
38261
D
Common Stock
616
I
401(k)
Non-Qualifed Stock Option (right to buy)
52.165
2018-07-02
4
M
0
21294
52.165
D
2024-02-13
Common Stock
21294.0
0
D
Non-Qualifed Stock Option (right to buy)
66.51
2018-07-02
4
M
0
38928
66.51
D
2026-02-25
Common Stock
38928.0
19464
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018.
This transaction was executed in multiple trades at prices ranging from $109.07 to $110.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $110.07 to $110.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $109.00 to $110.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $110.00 to $110.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $109.08 to $110.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $110.08 to $110.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017.
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
William J. O'Shaughnessy, Jr., Attorney in Fact for Everett Cunningham
2018-07-05